AAPlasma LLC is pleased to announce its participation in the Defense Manufacturing Conference (DMC), held March 30–April 2, 2026, at the Caribe Royale in Orlando, Florida.

Researchers from AAPlasma LLC and collaborators have published a new peer-reviewed study presenting a thermodynamic modeling framework for the destruction of polyol ester (POE) oils contaminated with the hydrofluorocarbon refrigerant R-134a using liquid-injection incineration supported by gliding arc plasma technology.

We are thrilled to announce that our company has been awarded a prestigious NIST SBIR Phase 1 grant.

We are thrilled to announce that on March 20, 2025, AAPlasma LLC officially joined The Ohio State University’s “Transformation of American Rubber through Domestic Innovation for Supply Security” (TARDISS) National Science Foundation (NSF) Engineering Research Center (ERC).

We are proud to announce our team's breakthrough research achievements in plasma-based disinfection and sanitation efforts, culminating in a Phase 1 SBIR award from NASA.

AAPlasma, in their support of Zephyro's efforts to control and convert CO2 emissions, teamed up with the fine folks at the Radical Development Center.

Our research manuscript was chosen for the cover of the Dermatology and Venereology Review journal.

The manuscript is on “The use of non-thermal atmospheric plasma for the treatment of in situ cutaneous squamous cell carcinoma: a case series.”

Greg Fridman, CEO and Charles Bailey, COO attended the 2023 Defense Manufacturing Conference (DMC) in Nashville, TN.

November 15, 2023, Philadelphia, PA

In order to expand our manufacturing capabilities, we are opening a second location for AAPlasma, located at 700 W Park Ave, Perkasie, PA 18944. This is a strategic co-location with our manufacturing partner, EFE Laboratories.